Biosynthesis and characterization of a novel genetically engineered polymer for targeted gene transfer to cancer cells.
about
Systematic engineering of uniform, highly efficient, targeted and shielded viral-mimetic nanoparticlesDual-targeted peptide-conjugated multifunctional fluorescent probe with AIEgen for efficient nucleus-specific imaging and long-term tracing of cancer cellsHybrid compounds: from simple combinations to nanomachines.Plasmid DNA delivery into MDA-MB-453 cells mediated by recombinant Her-NLS fusion protein.HSV-TK/GCV cancer suicide gene therapy by a designed recombinant multifunctional vector.Multivalent protein polymers with controlled chemical and physical properties.Production of low-expressing recombinant cationic biopolymers with high purity.Development of targeted recombinant polymers that can deliver siRNA to the cytoplasm and plasmid DNA to the cell nucleusRandom mutagenesis of amelogenin for engineering protein nanoparticles.Incorporation of histone derived recombinant protein for enhanced disassembly of core-membrane structured liposomal nanoparticles for efficient siRNA delivery.Advances with the use of bio-inspired vectors towards creation of artificial viruses.Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications.Development of recombinant cationic polymers for gene therapy research.Recombinant protein-based polymers for advanced drug delivery.Controlled release from recombinant polymersPeptide vectors for gene delivery: from single peptides to multifunctional peptide nanocarriers.Current status of gene therapy for breast cancer: progress and challenges.Factors influencing the nuclear targeting ability of nuclear localization signals.Enzyme/Prodrug Systems for Cancer Gene Therapy.Bispecific antibody complex pre-targeted delivery of polymer-drug conjugates for cancer therapy.Engineering of Escherichia coli for targeted delivery of transgenes to HER2/neu-positive tumor cells.Nano-biomimetic carriers are implicated in mechanistic evaluation of intracellular gene delivery.Structure prediction and validation of an affibody engineered for cell-specific nucleic acid targeting.Reducing the Visibility of the Vector/DNA Nanocomplexes to the Immune System by Elastin-Like Peptides.Bioengineering a non-genotoxic vector for genetic modification of mesenchymal stem cells.Development of a Recombinant Multifunctional Biomacromolecule for Targeted Gene Transfer to Prostate Cancer Cells.
P2860
Q28817710-4453CB27-96A3-42BB-99C0-1DF90BEF84AFQ33800277-5B38A96F-92FF-40A9-9FBE-91A87293D934Q34125590-8E091729-7B99-415E-BCDF-8F4B283C3B1BQ34231151-640A3C95-6B24-49CC-9D4F-D543D3D75AD6Q34507776-1A2CF5F2-0297-4163-87C8-813FCC80B29CQ34514739-30BAE8A9-5A74-45CB-B0BA-E66EB6CEBAD8Q34553603-861B766E-7E24-40FD-BACB-9201F5DA4FA4Q34851586-A7C991EC-A993-41ED-9ED9-5688EE6014E0Q35558223-B5EADA2C-AE5B-4858-B8D9-D6758F0B9226Q37251480-F620BDC9-401E-4940-9162-8BC2B903665DQ37691446-A396C9AD-ECC2-48F2-851B-C606F280A2F8Q37730252-561B9CD8-E8EA-44D7-9468-6FC5CD2A8476Q37732715-DD3CC633-E09A-456F-BD50-E4CEF82C1972Q37985590-C8D4D72F-8039-4E3E-817A-491B6B7D99BDQ38222535-7ADF9825-BC48-43B4-AC40-B459E5760D94Q38269128-4791A04F-D094-40C6-8899-7FF297EAB025Q38270806-BA347C88-184A-4149-A822-96620B7AA69EQ38820534-43076F2D-63C7-407E-8C0C-E86B879716C3Q39064497-46FB52A4-0D7F-4788-A76B-F804F59B8D8EQ39404483-B140A039-31E1-4600-A5CE-3992E5E5726EQ39588838-66DA8EF4-20BC-405A-AAF6-37E5CA72414DQ40362243-B1D07F1F-2E40-48B8-8976-4352E92C647CQ41965632-5479A400-D09B-4873-982A-6C5A67EBFCB1Q42151688-3E04F872-C289-433B-AE3D-074A543BCBBFQ47403404-9F1EA766-C8C9-48A9-92DA-B7D88AB2A9CAQ47796895-0807ADB5-2EFA-42D1-A719-4D926706CEEC
P2860
Biosynthesis and characterization of a novel genetically engineered polymer for targeted gene transfer to cancer cells.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Biosynthesis and characterizat ...... gene transfer to cancer cells.
@ast
Biosynthesis and characterizat ...... gene transfer to cancer cells.
@en
Biosynthesis and characterizat ...... gene transfer to cancer cells.
@nl
type
label
Biosynthesis and characterizat ...... gene transfer to cancer cells.
@ast
Biosynthesis and characterizat ...... gene transfer to cancer cells.
@en
Biosynthesis and characterizat ...... gene transfer to cancer cells.
@nl
prefLabel
Biosynthesis and characterizat ...... gene transfer to cancer cells.
@ast
Biosynthesis and characterizat ...... gene transfer to cancer cells.
@en
Biosynthesis and characterizat ...... gene transfer to cancer cells.
@nl
P2093
P2860
P1476
Biosynthesis and characterizat ...... gene transfer to cancer cells.
@en
P2093
Arash Hatefi
Brenda F Canine
Yuhua Wang
P2860
P304
P356
10.1016/J.JCONREL.2009.04.017
P407
P577
2009-04-18T00:00:00Z